Narlaprevir
Narlaprevir (trade name Arlansa, codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused by genotype 1 virus in combination with other antiviral drugs. Reference standards of Narlaprevir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Narlaprevir - API Standards
[catalogue_number] => PA 14 1440000
[category_ids] => ,78,70,82,76,77,
[chemical_name] =>
[weight] => 707.97
[form] => C36H61N5O7S
[cas] => 865466-24-6
[pslug] => 865466-24-6-narlaprevir-api-pa141440000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Narlaprevir - API Standards
Catalogue No.:PA 14 1440000
Molecular Formula : C36H61N5O7S
Molecular Weight : 707.97